| |
|
|
|
|
|
|
|||
|
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5621-5628. Prepublished online as a Blood First Edition Paper on April 1, 2008; DOI 10.1182/blood-2008-01-134155.
IMMUNOBIOLOGY Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells1 Institut de Pharmacologie et de Biologie Structurale (IPBS), Centre National de Recherche Scientifique (CNRS), Unité Mixte de Recherche 5089, Toulouse; and 2 Université Paul Sabatier, Toulouse, France Upon recognition of their respective cellular partners, T and B cells acquire their antigens by a process of membrane capture called trogocytosis. Here, we report that various inhibitors of actin polymerization or of kinases involved in intracellular signaling partially or fully inhibited trogocytosis by CD8+ and CD4+ T cells, whereas they had no effect on trogocytosis by B cells. Similarly, trogocytosis by T cells was inhibited at 4°C, whereas in B cells it was independent of temperature, indicating that trogocytosis by B cells does not rely on active processes. By contrast, most inhibitors we tested impaired both T-cell and B-cell activation. The differential effect of inhibitors on T-cell and B-cell trogocytosis was not due to the higher affinity of the B-cell receptor for its cognate antigen compared with the affinity of the T-cell receptor for its own antigen, but it correlated tightly with the abilities of T cells and B cells to form conjugates with their target cells in the presence of inhibitors. Trogocytosis thus has different requirements in different cell types. Moreover, the capture of membrane antigen by B cells is identified as a novel signaling-independent event of B-cell biology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||